The size of the European Thrombectomy Devices Market has been calculated at USD 0.28 billion in 2022. It is further projected to be growing at a CAGR of 7.5% and worth USD 0.40 billion by 2027.
Thrombectomy Devices is the removal of thrombi through surgical procedures in emergency cases, which can block blood circulation. It is usually the final resort as a long-term hindrance of blood flow to organs can lead to necrosis. Thrombi refers to blood clots, but in ordinary usage, it can refer to any material which blocks the blood flow and can lead to health complications.
Some of the frequently used Thrombectomy Devices procedures are surgical embolectomy, balloon embolectomy, and aspiration embolectomy. Surgical embolectomy involves the removal of a clot by surgical incision into an artery. Aspiration embolectomy procedure involves removal of thrombus using suction instead of a balloon. It is a quick and effective way to remove thrombi in limb arteries. In balloon embolectomy, the catheter is inserted, which has an inflatable balloon at its tip. It is inserted into a blood clot and inflated, and then the balloon is removed along with the clot. Some of the complications involved in the procedure are the possibility of intimal lesions, leading to another thrombosis.
Some of the driving factors of the European Thrombectomy Devices market are the increasing prevalence of cardiovascular diseases, rising sedentary lifestyle, increasing demand for minimally invasive procedures, technological innovations in the medical field, and growing geriatric population. The restraints faced by this market are difficulty in using new equipment, lack of skilled workers, and lack of awareness about peripheral vascular diseases.
This research report on the European Thrombectomy Devices Market has been segmented and sub-segmented into the following categories:
By End Users:
Geographically, Europe has the second largest market share in the world. Factors such as rising technological innovations, growing geriatric population, and increased incidence of cardiovascular diseases are expected to propel this market's growth in the region.
Notable companies operating in the European Thrombectomy Devices Market Profiled in the Report are Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.), Terumo Corporation (Japan), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com